217 related articles for article (PubMed ID: 9309462)
1. Unpredictable cases of complicated ovarian hyperstimulation in IVF.
Delvigne A; Vandromme J; Demeestere I; Leroy F
Int J Fertil Womens Med; 1997; 42(4):268-70. PubMed ID: 9309462
[TBL] [Abstract][Full Text] [Related]
2. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
[TBL] [Abstract][Full Text] [Related]
3. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
5. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
6. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
7. [Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection].
Lin J; Ye B; Zhao J; Zhou Y; Huang X; Zheng J
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):601-3. PubMed ID: 12487934
[TBL] [Abstract][Full Text] [Related]
8. Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization.
Kahnberg A; Enskog A; Brännström M; Lundin K; Bergh C
Acta Obstet Gynecol Scand; 2009; 88(12):1373-81. PubMed ID: 19878052
[TBL] [Abstract][Full Text] [Related]
9. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
[TBL] [Abstract][Full Text] [Related]
10. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
11. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
12. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
[TBL] [Abstract][Full Text] [Related]
13. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
[TBL] [Abstract][Full Text] [Related]
15. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
16. Number of oocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome.
Reljic M; Vlaisavljević V; Gavrić V; Kovacic B
J Reprod Med; 1999 Aug; 44(8):713-8. PubMed ID: 10483542
[TBL] [Abstract][Full Text] [Related]
17. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome.
Delvigne A; Kostyla K; Murillo D; Van Hoeck J; Rozenberg S
Int J Fertil Womens Med; 2003; 48(1):25-31. PubMed ID: 12643517
[TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
Várnagy A; Bódis J; Mánfai Z; Wilhelm F; Busznyák C; Koppán M
Fertil Steril; 2010 May; 93(7):2281-4. PubMed ID: 19261278
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
20. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
Mansour R; Aboulghar M; Serour G; Amin Y; Abou-Setta AM
Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
